A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hsiao, Hsi Min ^a   Sapinoro, Ramil E ^b   Thatcher, Thomas H ^b   Croasdell, Amanda ^b   Levy, Elizabeth P ^b   Fulton, Robert A ^b   Olsen, Keith C ^a,b   Pollock, Stephen J ^b   Serhan, Charles N ^c   Phipps, Richard P ^a,b   Sime, Patricia J ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RESOLVIN D1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; SMOKING; SMOKING CESSATION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DNA PRIMERS; DOCOSAHEXAENOIC ACIDS; FEMALE; FIBROBLASTS; HOMEOSTASIS; HUMANS; LUNG; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; PNEUMONIA; SMOKING;

EID: 84874643958     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058258     Document Type: Article

References (58)

1. Decramer M, Janssens W, Miravitlles M, (2012) Chronic obstructive pulmonary disease. Lancet 379: 1341-1351.
2. Cosio MG, Saetta M, Agusti A, (2009) Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360: 2445-2454.
3. Serhan CN, (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? The American journal of pathology 177: 1576-1591.
4. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, et al. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. The Journal of biological chemistry 282: 9323-9334.
5. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, et al. (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proceedings of the National Academy of Sciences of the United States of America 102: 7671-7676.
6. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, et al. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. The Journal of experimental medicine 196: 1025-1037.
7. Chen YF, Jiang H, Gong X, Wan JY, (2011) [Resolvin E1 protects against ox-LDL-induced injury on vascular endothelial cells]. Zhonghua Xin Xue Guan Bing Za Zhi 39: 1039-1043.
8. Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, et al. (2010) The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. Journal of immunology 184: 836-843.
9. Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, et al. (2007) Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. Journal of immunology 178: 496-502.
10. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH, (1989) The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 139: 1395-1400.
11. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, et al. (1994) Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 331: 228-233.
12. Martey CA, Pollock SJ, Turner CK, O'Reilly KM, Baglole CJ, et al. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287: L981-991.
13. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, et al. (2006) Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291: L46-57.
14. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, et al. (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142: 481-489.
15. Tuder RM, Petrache I, (2012) Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 122: 2749-2755.
16. Gordon S, Martinez FO, (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
17. Biswas SK, Mantovani A, (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11: 889-896.
18. Kent LM, Fox SM, Farrow SN, Singh D, (2010) The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages. International immunopharmacology 10: 57-64.
19. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, et al. (2009) Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. American journal of respiratory and critical care medicine 179: 1011-1021.
20. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, et al. (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. American journal of respiratory cell and molecular biology 37: 748-755.
21. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, et al. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282: 9323-9334.
22. Duffield JS, Hong S, Vaidya VS, Lu Y, Fredman G, et al. (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. Journal of immunology 177: 5902-5911.
23. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB, (2011) Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. Journal of immunology 187: 1957-1969.
24. Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, et al. (2012) Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol.
25. Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, et al. (2012) Resolvin d1 and aspirin-triggered resolvin d1 promote resolution of allergic airways responses. Journal of immunology 189: 1983-1991.
26. Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, et al. (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. Journal of immunology 187: 5408-5418.
27. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, et al. (2011) Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 41: 366-379.
28. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, et al. (1995) CD40 expression by human fibroblasts. Clinical immunology and immunopathology 77: 42-51.
29. Caito S, Yang SR, Kode A, Edirisinghe I, Rajendrasozhan S, et al. (2008) Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. Antioxid Redox Signal 10: 253-260.
30. Yokohori N, Aoshiba K, Nagai A, (2004) Respiratory Failure Research Group in J (2004) Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 125: 626-632.
31. Thatcher TH, McHugh NA, Egan RW, Chapman RW, Hey JA, et al. (2005) Role of CXCR2 in cigarette smoke-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 289: L322-328.
32. Thatcher TH, Benson RP, Phipps RP, Sime PJ, (2008) High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function. American journal of physiology Lung cellular and molecular physiology 295: L412-421.
33. Koumas L, Smith TJ, Phipps RP, (2002) Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. European journal of immunology 32: 477-485.
34. Xu J, Xu F, Barrett E, (2008) Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. Am J Physiol Lung Cell Mol Physiol 295: L162-170.
35. Martey CA, Pollock SJ, Turner CK, O'Reilly KM, Baglole CJ, et al. (2004) Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. American journal of physiology Lung cellular and molecular physiology 287: L981-991.
36. Profita M, Sala A, Bonanno A, Riccobono L, Ferraro M, et al. (2010) Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. American journal of physiology Lung cellular and molecular physiology 298: L261-269.
37. Thatcher TH, McHugh NA, Egan RW, Chapman RW, Hey JA, et al. (2005) Role of CXCR2 in cigarette smoke-induced lung inflammation. American journal of physiology Lung cellular and molecular physiology 289: L322-328.
38. Thatcher TH, Maggirwar SB, Baglole CJ, Lakatos HF, Gasiewicz TA, et al. (2007) Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. The American journal of pathology 170: 855-864.
39. Uddin M, Levy BD, (2011) Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 50: 75-88.
40. Botelho FM, Bauer CM, Finch D, Nikota JK, Zavitz CC, et al. (2011) IL-1alpha/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS One 6: e28457.
41. Shapiro SD, (2004) Smoke gets in your cells. Am J Respir Cell Mol Biol 31: 481-482.
42. Martey CA, Baglole CJ, Gasiewicz TA, Sime PJ, Phipps RP, (2005) The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 289: L391-399.
43. Thatcher TH, Maggirwar SB, Baglole CJ, Lakatos HF, Gasiewicz TA, et al. (2007) Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol 170: 855-864.
44. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN, (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612-619.
45. Vachier I, Chanez P, Bonnans C, Godard P, Bousquet J, et al. (2002) Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun 290: 219-224.
46. Baines KJ, Simpson JL, Gibson PG, (2011) Innate immune responses are increased in chronic obstructive pulmonary disease. PloS one 6: e18426.
47. Minematsu N, Blumental-Perry A, Shapiro SD, (2011) Cigarette smoke inhibits engulfment of apoptotic cells by macrophages through inhibition of actin rearrangement. American journal of respiratory cell and molecular biology 44: 474-482.
48. Abboud RT, Vimalanathan S, (2008) Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 12: 361-367.
49. Spite M, Norling LV, Summers L, Yang R, Cooper D, et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461: 1287-1291.
50. El Kebir D, Gjorstrup P, Filep JG (2012) Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci U S A.
51. Recchiuti A, Krishnamoorthy S, Fredman G, Chiang N, Serhan CN, (2011) MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J 25: 544-560.
52. Tanaka T, Terada M, Ariyoshi K, Morimoto K, (2010) Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation. Biochemical and biophysical research communications 399: 677-682.
53. Ogawa Y, Duru EA, Ameredes BT, (2008) Role of IL-10 in the resolution of airway inflammation. Current molecular medicine 8: 437-445.
54. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, et al. (1999) Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 14: 309-314.
55. Burgess JL, Nanson CJ, Hysong TA, Gerkin R, Witten ML, et al. (2002) Rapid decline in sputum IL-10 concentration following occupational smoke exposure. Inhalation toxicology 14: 133-140.
56. Joo MJ, Au DH, Fitzgibbon ML, Lee TA, (2010) Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respiratory medicine 104: 246-252.
57. Invernizzi G, Ruprecht A, De Marco C, Mazza R, Nicolini G, et al. (2009) Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance. Respiratory research 10: 48.
58. Schwab JM, Chiang N, Arita M, Serhan CN, (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447: 869-874.